Clinical Trials Browser

Recruiting × toripalimab × Gynecologic × Clear all

NCT04918186 2026-02-12

IPROC

Phase 2 Recruiting

Ovarian Neoplasms

NCT07092696 2025-07-30

Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT06093438 2025-03-11

Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer

Phase 1/2 Recruiting

Uterine Cervical Neoplasms

NCT06028672 2025-02-06

TA56

Phase NA Recruiting

Gestational Trophoblastic Disease

NCT06020755 2024-12-31

TA7

Phase 2 Recruiting

Gestational Trophoblastic Disease

NCT05955105 2024-05-21

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Phase 1/2 Recruiting

BreastDermatologicGynecologicHead & NeckSarcomaThoracic

Nasopharyngeal Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06256224 2024-04-24

Toripalimab Combined With Definitive CCRT for LACC Patients

Phase NA Recruiting

Uterine Cervical Neoplasms